Ask AI

LEN PrEP Utilization in Real-world US Settings

Conference Coverage Slideset
Conference Coverage Slideset Start Activity

Released: October 27, 2026

See Activity Collection

This epidemiologic study characterized early utilization of injectable lenacapavir PrEP in real-world US settings during the first 9 months after FDA approval. Investigators report LEN utilization among a diverse population of individuals, including women, people with no previous PrEP experience, and people with prior oral and injectable PrEP experience.

Real World LEN PrEP

Activity Information

Released: October 27, 2026